0.7884
price up icon2.01%   0.0155
after-market 시간 외 거래: .80 0.0116 +1.47%
loading

Immunic Inc 주식(IMUX)의 최신 뉴스

pulisher
08:45 AM

Immunic Therapeutics reaches major milestone with completion of ENSURE Trial Enrollment - Proactive Investors

08:45 AM
pulisher
Jun 05, 2025

Immunic at Jefferies Conference: Promising MS Drug Insights - Investing.com Australia

Jun 05, 2025
pulisher
Jun 05, 2025

Small cap wrap: Midnight Sun Mining, Standard Uranium, Immunic, ReconAfrica... - Proactive financial news

Jun 05, 2025
pulisher
Jun 05, 2025

Market movers: Tesla, Verint, PVH, Immunic... - Proactive financial news

Jun 05, 2025
pulisher
Jun 05, 2025

Immunic (IMUX) Receives Continued 'Buy' Rating from D. Boral Cap - GuruFocus

Jun 05, 2025
pulisher
Jun 05, 2025

Immunic completes patient enrollment in Phase 3 relapsing multiple sclerosis trials - Proactive financial news

Jun 05, 2025
pulisher
Jun 05, 2025

Immunic Completes Enrollment in 2 Phase 3 Studies in Relapsing Multiple Sclerosis - marketscreener.com

Jun 05, 2025
pulisher
Jun 05, 2025

IMUX: Promising Results of Vidofludimus Calcium in Multiple Sclerosis Treatment | IMUX Stock News - GuruFocus

Jun 05, 2025
pulisher
Jun 05, 2025

IMUX Completes Enrollment for Phase 3 Trials in Multiple Scleros - GuruFocus

Jun 05, 2025
pulisher
Jun 05, 2025

Immunic Announces Completion of Enrollment for Both Phase 3 ENSURE Trials in Relapsing MS and Presents Additional Data Underlining Positive Outcome of Phase 2 CALLIPER Trial in Progressive MS | IMUX S - GuruFocus

Jun 05, 2025
pulisher
Jun 05, 2025

Immunic Announces Completion of Enrollment for Both Phase 3 ENSURE Trials in Relapsing MS and Presents Additional Data Underlining Positive Outcome of Phase 2 CALLIPER Trial in Progressive MS - Yahoo Finance

Jun 05, 2025
pulisher
Jun 04, 2025

Top Executives Make Bold Moves with Major Immunic Stock Purchases! - TipRanks

Jun 04, 2025
pulisher
Jun 04, 2025

Immunic Approves Equity Plan Amendment at Annual Meeting - TipRanks

Jun 04, 2025
pulisher
Jun 03, 2025

Immunic, Inc. Announces Closing of Oversubscribed $65 Million Underwritten Public Offering | IMUX Stock News - GuruFocus

Jun 03, 2025
pulisher
Jun 03, 2025

Immunic Announces Closing Of Oversubscribed $65 Million Underwritten Public Offering - marketscreener.com

Jun 03, 2025
pulisher
Jun 03, 2025

Immunic, Inc. Announces Closing of Oversubscribed $65 Million Underwritten Public Offering - Longview News-Journal

Jun 03, 2025
pulisher
Jun 03, 2025

Immunic raises $65M in public offering to fund clinical trials - Proactive financial news

Jun 03, 2025
pulisher
Jun 02, 2025

Immunic to Participate in Investor, Scientific and Industry Conf - GuruFocus

Jun 02, 2025
pulisher
Jun 02, 2025

Immunic Showcases Breakthrough MS Drug Data at 6 Major Healthcare Conferences This Month - Stock Titan

Jun 02, 2025
pulisher
Jun 02, 2025

Immunic releases June conference schedule - Proactive Investors

Jun 02, 2025
pulisher
May 30, 2025

Immunic Announces $65 Million Public Offering - TipRanks

May 30, 2025
pulisher
May 30, 2025

Immunic, Inc. Announces Pricing of Oversubscribed $65 Million Underwritten Public Offering - Eastern Progress

May 30, 2025
pulisher
May 30, 2025

Immunic Inc. prices $65 million public offering By Investing.com - Investing.com South Africa

May 30, 2025
pulisher
May 30, 2025

Immunic (NASDAQ:IMUX) Price Target Lowered to $10.00 at D. Boral Capital - Defense World

May 30, 2025
pulisher
May 29, 2025

Immunic (IMUX) Launches $65M Public Offering, Shares Drop - GuruFocus

May 29, 2025
pulisher
May 29, 2025

Immunic Tumbles After Pricing $65 Million Offering of Warrants - marketscreener.com

May 29, 2025
pulisher
May 29, 2025

Immunic, Inc. Announces Pricing of Oversubscribed $65 Million Un - GuruFocus

May 29, 2025
pulisher
May 29, 2025

Small cap wrap: Fineqia, Synchronoss, Santacruz Silver, Immunic... - Proactive financial news

May 29, 2025
pulisher
May 29, 2025

Immunic (IMUX) Receives Target Price Adjustment from D. Boral Ca - GuruFocus

May 29, 2025
pulisher
May 29, 2025

Immunic (IMUX) Faces Price Target Reduction Amid Stock Offering - GuruFocus

May 29, 2025
pulisher
May 29, 2025

Immunic (IMUX) Faces Price Target Reduction Amid Stock Offering | IMUX Stock News - GuruFocus

May 29, 2025
pulisher
May 29, 2025

Immunic (IMUX) Launches Public Offering with Warrant Options | I - GuruFocus

May 29, 2025
pulisher
May 29, 2025

Immunic shares fall 12% after pricing of $65 million underwritten public offering to fund trials - Seeking Alpha

May 29, 2025
pulisher
May 29, 2025

Immunic to raise up to $65M in underwritten public offering - Proactive Investors

May 29, 2025
pulisher
May 29, 2025

Immunic (IMUX) Launches Public Offering with Warrant Options | IMUX Stock News - GuruFocus

May 29, 2025
pulisher
May 29, 2025

Immunic Announces Pricing Of Oversubscribed $65 Million Underwritten Public Offering - marketscreener.com

May 29, 2025
pulisher
May 29, 2025

Immunic Inc. prices $65 million public offering - Investing.com

May 29, 2025
pulisher
May 29, 2025

Immunic, Inc. Announces Proposed Public Offering - Longview News-Journal

May 29, 2025
pulisher
May 29, 2025

Immunic Announces Pricing of Oversubscribed $65 Million Underwritten Public Offering - Investing.com Nigeria

May 29, 2025
pulisher
May 28, 2025

Immunic launches public offering of warrants to fund clinical trials; shares down - MSN

May 28, 2025
pulisher
May 28, 2025

Immunic slides on planned equity raise - TradingView

May 28, 2025
pulisher
May 28, 2025

Immunic (IMUX) Launches Public Offering with Pre-Funded and Warr - GuruFocus

May 28, 2025
pulisher
May 28, 2025

Immunic announces public offering of warrants to fund trials - Investing.com India

May 28, 2025
pulisher
May 28, 2025

Immunic announces public offering of warrants to fund trials By Investing.com - Investing.com Canada

May 28, 2025
pulisher
May 28, 2025

Immunic (IMUX) Launches Public Offering with Pre-Funded and Warrants | IMUX Stock News - GuruFocus

May 28, 2025
pulisher
May 28, 2025

Immunic Announces Public Offering to Fund Trials - TipRanks

May 28, 2025
pulisher
May 28, 2025

Biotech Immunic Launches Strategic Public Offering to Advance Inflammatory Disease Pipeline - Stock Titan

May 28, 2025
pulisher
May 27, 2025

Immunic's IMU-856 shows promise as Celiac Disease Awareness Month draws to a close - Proactive Investors

May 27, 2025
pulisher
May 26, 2025

Immunic’s (IMUX) Buy Rating Reiterated at B. Riley - Defense World

May 26, 2025
pulisher
May 23, 2025

Analyst Adjusts Target Price for Immunic (IMUX) Amid Strategic F - GuruFocus

May 23, 2025
pulisher
May 23, 2025

Immunic (IMUX) Price Target Lowered by B. Riley Securities | IMU - GuruFocus

May 23, 2025
pulisher
May 23, 2025

Analyst Adjusts Target Price for Immunic (IMUX) Amid Strategic Financing Prospects | IMUX Stock News - GuruFocus

May 23, 2025
pulisher
May 23, 2025

B. Riley Cuts Price Target on Immunic to $5 From $6, Keeps Buy Rating - marketscreener.com

May 23, 2025
pulisher
May 21, 2025

Janus Henderson Group PLC Cuts Stock Holdings in Immunic, Inc. (NASDAQ:IMUX) - Defense World

May 21, 2025
pulisher
May 20, 2025

Immunic, Inc. (NASDAQ:IMUX) Receives $13.20 Average Price Target from Analysts - Defense World

May 20, 2025
pulisher
May 16, 2025

Immunic: Q1 Earnings Snapshot - CT Insider

May 16, 2025
$1.15
price up icon 0.00%
$585.93
price up icon 0.92%
$300.83
price down icon 2.33%
$38.11
price up icon 4.29%
$4.73
price down icon 1.69%
$493.22
price up icon 2.10%
자본화:     |  볼륨(24시간):